Open enrollment for 2026 health insurance coverage is underway, and many Indianapolis residents may see higher premiums and fewer savings as federal subsidies are set to expire next year. According to ...

Premiums for the most popular types of plans sold on the federal health insurance marketplace Healthcare.gov will spike on average by 30% next year, according to final rates approved by the Centers ...

People can now view healthcare plan estimates on the Georgia Access website ahead of open enrollment, which begins November 1. ‘Predator: Badlands’ early reviews are all leaning one way Poll Deals ...

Sazerac Company is planning to inject over $38m in expanding operations at its US facility in New Albany, Indiana, managed by its subsidiary Northwest Ordinance Distilling. The investment, includes ...

Hoosiers football is so hot right now. With a win over Oregon in Eugene on Saturday, Indiana is now No. 3 in the AP college football poll, which is the best ranking in the program’s history. TV ...

© 2004-2025 CBS Interactive. ALL RIGHTS RESERVED. CBS Sports is a registered trademark of CBS Broadcasting Inc. Commissioner.com is a registered trademark of CBS ...

Though listed as a quarterback, Knox, Indiana's Myles McLaughlin is a dominant runner who, according to Max Preps, is leading the nation with 2,106 rushing yards and 33 touchdowns through six games.

Planners involved with a massive redevelopment project along the Ohio River in Jeffersonville say a recent grant will help catapult movement on the endeavor. American Commercial Barge Line, which owns ...

JEFFERSONVILLE, Ind. — The Jeffboat site, an abandoned shipyard in Jeffersonville, Ind., received a $20 million grant from the state from Lilly Endowment Inc., inching the historic barge closer to a ...

Indiana and Northwestern face off in a Big Ten volleyball clash on Wednesday night. Here's everything you need to know to watch the match: Indiana has opened their 2025 campaign strong with a 9-1 ...

Scholar Rock’s bid to become the first company to win FDA approval for a muscle-targeted treatment for spinal muscular atrophy (SMA) has been tripped up by a manufacturing issue. The FDA sent a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Michigan man was arrested in ...